| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| PCT/US2014/037201WO2015171142A1 (en) | 2014-05-07 | 2014-05-07 | Therapeutic placental compositions, methods of making and methods of use | 
| Publication Number | Publication Date | 
|---|---|
| EP3139935A1 EP3139935A1 (en) | 2017-03-15 | 
| EP3139935A4true EP3139935A4 (en) | 2017-11-15 | 
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| EP14891336.1AWithdrawnEP3139935A4 (en) | 2014-05-07 | 2014-05-07 | Therapeutic placental compositions, methods of making and methods of use | 
| Country | Link | 
|---|---|
| EP (1) | EP3139935A4 (en) | 
| JP (1) | JP2017514876A (en) | 
| KR (1) | KR20160147058A (en) | 
| AU (1) | AU2014393402A1 (en) | 
| CA (1) | CA2948126A1 (en) | 
| SG (1) | SG11201609254YA (en) | 
| WO (1) | WO2015171142A1 (en) | 
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US20110212065A1 (en) | 2010-02-18 | 2011-09-01 | Timothy Jansen | Methods of manufacture of therapeutic products comprising vitalized placental dispersions | 
| JP7011135B2 (en)* | 2016-02-19 | 2022-02-10 | 佳秀工業株式会社 | A method for producing a vascular endothelial growth factor production promoter and a hair growth agent, and a vascular endothelial growth factor production promoter and a hair growth agent. | 
| CN114404454A (en)* | 2016-03-14 | 2022-04-29 | 无痛疗法股份有限公司 | acellular placenta preparation | 
| WO2017165698A1 (en)* | 2016-03-23 | 2017-09-28 | Mimedx Group, Inc. | Compositions and methods of treatment with amniotic fluid | 
| AU2017316682B2 (en) | 2016-08-24 | 2020-10-15 | Arthrex, Inc. | Tissue use for repair of injury | 
| WO2018144694A1 (en) | 2017-02-01 | 2018-08-09 | Plakous Therapeutics, Inc. | Placental tissue compositions | 
| US11511017B2 (en) | 2019-03-12 | 2022-11-29 | Arthrex, Inc. | Ligament reconstruction | 
| WO2021003257A1 (en)* | 2019-07-01 | 2021-01-07 | Auxocell Laboratories, Inc. | Methods and compositions for collecting and using placental tissue cells and placental blood cells | 
| AU2020386363A1 (en)* | 2019-11-21 | 2022-05-19 | Bioventus, Llc . | Placental tissue particulate compositions and methods of use | 
| WO2021123320A1 (en)* | 2019-12-20 | 2021-06-24 | Dr. Kalali Prof. Mostafazadeh Dipl. Ing. Miedl (Kmm) Gesellschaft Bürgerlichen Rechts | A composition and its use for a universal therapy against tumor cells | 
| KR102116954B1 (en)* | 2019-12-26 | 2020-05-29 | 주식회사 엠케이바이오텍 | Composition for cryopreservation and lyophilization of fetal stem cells | 
| AU2021257255A1 (en)* | 2020-04-17 | 2022-11-24 | Crown Scientific, L.L.C. | Regenerative nonsteroidal anti-inflammatory compositions, methods of production, and methods of use thereof | 
| US12426594B2 (en) | 2020-09-24 | 2025-09-30 | Everest Medical Innovation GmbH | Cryoprotective compositions and methods for protection of a surgical site during cryosurgery | 
| US20240165166A1 (en)* | 2020-10-06 | 2024-05-23 | Osiris Therapeutics, Inc. | Primed placental tissue and uses in regenerative medicine | 
| US20240189364A1 (en)* | 2021-02-26 | 2024-06-13 | Arugula Sciences Llc | Villi stromal cells compositions and uses thereof | 
| US20250213461A1 (en)* | 2022-04-01 | 2025-07-03 | Bright Cell, Inc. | A mesenchymal stem cells formulation for cosmetic use | 
| US20240226181A1 (en)* | 2023-01-11 | 2024-07-11 | Biostem Technologies, Inc. | Human umbilical cord composition for treatment of peyronie's disease | 
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| WO2009120996A1 (en)* | 2008-03-27 | 2009-10-01 | Biolife Solutions, Inc. | Mehtod, system, and apparatus for hypothermic collection, storage, transport and banking of birth tissue | 
| EP2702871A1 (en)* | 2002-03-26 | 2014-03-05 | Anthrogenesis Corporation | Collagen biofabric and methods of preparation and use therefor | 
| US20140106447A1 (en)* | 2012-10-12 | 2014-04-17 | Mimedx Group, Inc. | Compositions and methods for recruiting stem cells | 
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| JP5101778B2 (en)* | 2000-02-11 | 2012-12-19 | ザ ジェネラル ホスピタル コーポレイション | Tissue adhesion by photochemical action | 
| US11191789B2 (en)* | 2003-06-27 | 2021-12-07 | DePuy Synthes Products, Inc. | Cartilage and bone repair and regeneration using postpartum-derived cells | 
| US20110212065A1 (en)* | 2010-02-18 | 2011-09-01 | Timothy Jansen | Methods of manufacture of therapeutic products comprising vitalized placental dispersions | 
| US8632512B2 (en)* | 2010-04-09 | 2014-01-21 | Kci Licensing, Inc. | Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds | 
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| EP2702871A1 (en)* | 2002-03-26 | 2014-03-05 | Anthrogenesis Corporation | Collagen biofabric and methods of preparation and use therefor | 
| WO2009120996A1 (en)* | 2008-03-27 | 2009-10-01 | Biolife Solutions, Inc. | Mehtod, system, and apparatus for hypothermic collection, storage, transport and banking of birth tissue | 
| US20140106447A1 (en)* | 2012-10-12 | 2014-04-17 | Mimedx Group, Inc. | Compositions and methods for recruiting stem cells | 
| Title | 
|---|
| JI SUK CHOI ET AL: "Full-Thickness Skin Wound Healing Using Human Placenta-Derived Extracellular Matrix Containing Bioactive Molecules", TISSUE ENGINEERING PART A, vol. 19, no. 3-4, 1 February 2013 (2013-02-01), pages 329 - 339, XP055395217, ISSN: 1937-3341, DOI: 10.1089/ten.tea.2011.0738* | 
| Publication number | Publication date | 
|---|---|
| WO2015171142A1 (en) | 2015-11-12 | 
| CA2948126A1 (en) | 2015-11-12 | 
| KR20160147058A (en) | 2016-12-21 | 
| AU2014393402A1 (en) | 2016-11-24 | 
| JP2017514876A (en) | 2017-06-08 | 
| SG11201609254YA (en) | 2016-12-29 | 
| EP3139935A1 (en) | 2017-03-15 | 
| Publication | Publication Date | Title | 
|---|---|---|
| IL322086A (en) | Therapeutic compositions, combinations, and methods of use | |
| EP3139935A4 (en) | Therapeutic placental compositions, methods of making and methods of use | |
| EP3242672A4 (en) | Amnion derived therapeutic composition and process of making same | |
| EP3245291A4 (en) | Novel micro-dystrophins and related methods of use | |
| EP3199628A4 (en) | Cytotoxicity-inducing therapeutic agent | |
| EP3160470A4 (en) | Analogs of pridopidine, their preparation and use | |
| EP3167046A4 (en) | Manufacture and cryopreservation of fucosylated cells for therapeutic use | |
| EP3104948A4 (en) | Parent-infant-interactive, sensory-stimulation toy and methods of use | |
| EP3204386A4 (en) | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | |
| EP3102200A4 (en) | Therapeutic compounds and compositions | |
| EP3194564A4 (en) | Trichoderma compositions and methods of use | |
| EP3265096A4 (en) | Ophthalmic compositions and methods of use therefor | |
| EP3139928A4 (en) | Anordrin compositions and methods for treating diseases | |
| EP3094606A4 (en) | Cement compositions, structures, and methods of use | |
| EP3166892A4 (en) | Scale-inhibition compositions and methods of making and using the same | |
| EP3125963A4 (en) | Tissue filler compositions and methods of use | |
| EP3110446A4 (en) | Methods and compositions for treating siglec-8 associated diseases | |
| EP3190886A4 (en) | Compositions and methods of use thereof | |
| EP3224362A4 (en) | Therapeutic compositions comprising transcription factors and methods of making and using the same | |
| EP3136879A4 (en) | Concentrated protein compositions and methods of their making and use | |
| EP3117827A4 (en) | Composition for vagina and use of the composition | |
| EP3131556A4 (en) | Methods and compositions for treatment of copd diseases | |
| EP3247365A4 (en) | Novel iodophor composition and methods of use | |
| EP3297619A4 (en) | Therapeutic uses of l-4-chlorokynurenine | |
| EP3185910A4 (en) | Methods and compositions for the treatment of cancer | 
| Date | Code | Title | Description | 
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase | Free format text:ORIGINAL CODE: 0009012 | |
| 17P | Request for examination filed | Effective date:20161118 | |
| AK | Designated contracting states | Kind code of ref document:A1 Designated state(s):AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR | |
| AX | Request for extension of the european patent | Extension state:BA ME | |
| DAX | Request for extension of the european patent (deleted) | ||
| A4 | Supplementary search report drawn up and despatched | Effective date:20171013 | |
| RIC1 | Information provided on ipc code assigned before grant | Ipc:A61K 35/50 20150101AFI20171009BHEP Ipc:A61P 17/02 20060101ALI20171009BHEP | |
| 17Q | First examination report despatched | Effective date:20180702 | |
| STAA | Information on the status of an ep patent application or granted ep patent | Free format text:STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN | |
| 18D | Application deemed to be withdrawn | Effective date:20181113 |